Immuno-Oncology Innovation Award

Submit your abstract to apply for our travel award

Apply now

 

Miltenyi Biotec is excited to honor researchers around the globe for their contributions to the immuno-oncology field. Innovative research will be awarded with travel, accommodation, and registration to selected immuno-oncology meetings. In addition, the winner will have the opportunity to share his or her research with the scientific community.

Check out the list of upcoming meetings that are covered by our Immuno-Oncology Innovation Award below and submit your abstract within the given timeline to apply for the award.

Upcoming meetings covered by our Immuno-Oncology Innovation Award*:

American Association for Cancer Research (AACR) Annual Meeting 2020
Due to the postponing for AACR 2020, we have extended our deadlines to apply for the IOIA, don't miss your chance to submit your abstract! 

April 24-29, 2020  | San Diego, California. (Check AACR website for official rescheduled date)
Abstract submission deadline: Currently accepting abstracts
Travel award winner announcement: TBC 

16th International Symposium on Dendritic Cells 2020
October 11-15, 2020  |  Queensland, Australia
Abstract submission deadline: August 26, 2020
Travel award winner announcement: September 10, 2020 

*This contest is open for participation, at no charge, according to the respective deadlines.
Simply fill out the form at the end of this page to submit your abstract.
 

Check out what the winners of our previous travel awards have to say: 

I would like to thank Miltenyi for selecting my work for the Immuno-Oncology Innovation Award.  The NK meeting in Luxembourg was an inspiring meeting and an outstanding opportunity to hear about the latest advances in NK cell biology. Discussing my work with other scientists during the excellent poster sessions, left me with many new ideas for my research. 
Ms. Femke Ehlers | Winner of the IOIA 2019 - The 18th Meeting of the Society for Natural Immunity, Luxembourg 
I was very honored and excited to receive the Immunology-Oncology Innovation Award. AACR meeting at Atlanta was an excellent opportunity to meet scientists across the globe and share my work with them. I would like to thank Miltenyi for supporting young scientists like me and providing this wonderful opportunity. 
Ms. Nehal Gupta | Winner of the IOIA 2019 - American Association for Cancer Research (AACR) Annual Meeting  
Ph.D candidate, Texas Tech University Health Sciences Center
„It was a great honor for me to have my work so highly appreciated by Miltenyi Biotec. Attending the ASH 2018 in San Diego was an amazing experience, which allowed me to interact with top scientists from all over the world, to discuss my work and to initiate new partnerships.”
Mgr. Michal ŠMÍDA | Winner of the IOIA 2018 – American Society of Hematology (ASH) Annual Meeting 
Central European Institute of Technology (CEITEC) Masaryk University in Brno, Czech Republic
Michal Smida, Ph.D., is a junior research group leader at the CEITEC. His research focuses on personalized medicine for B cell malignancies, in particular developing alternative strategies to combine with immunotherapy regimens and predicting novel therapy targets based on synthetic lethality with patient mutations. His team is mainly using CRISPR/Cas9-based gene editing and cell screening with both whole-genome CRISPR knockout as well as drug libraries.
“The Chicago AACR meeting was an outstanding experience for me. I found the opportunity to interact with leaders in the field and to witness firsthand the excitement in cancer immunology to be extremely motivating. I am honored to have my work recognized by Miltenyi and would like to thank you for your dedication to innovation in immuno-oncology.”
Brian Koss | Winner of the IOIA 2018 – American Association for Cancer Research (AACR) 
University of Arkansas for Medical Sciences, Biochemistry and Molecular Biology, United States 
Brian Koss is a Ph.D. student in the Tackett lab. He specializes in the use of mass spectrometry for analysis of 
histone post-translational modifications. His current work focuses on defining epigenetic mechanisms 
driving metabolic exhaustion of tumor-infiltrating lymphocytes. 
“The San Antonio NK meeting was a really great event to hear about the latest advances in science and a great opportunity to present my work. This award is also a good way to show Miltenyi’s interest in students’ projects. This travel grant allowed me to meet a lot of amazing scientists and to discuss my project and plans with them. I’m very grateful to Miltenyi for this opportunity.”
Aurelien Colamartino | Winner of the IOIA – The 17th Meeting of the Society for Natural Immunity 
University of Montreal, CRCHU Sainte-Justine, Montreal 
Aurélien Colamartino is a Ph.D. student in the Haddad lab. His work focuses on a new, highly efficient transduction method to customize NK cells for immunotherapy, using different pseudotyped lentiviral particles.
"I was very honored to receive the Immunology-Oncology Innovation Award, which gave me the opportunity to attend an excellent conference and to present my data. Miltenyi's commitment to support innovation and young scientists is a valuable strategy to move the onco-immunology field forward."
Damya Laoui | Winner of the IOIA 2018 – 15th International Symposium on Dendritic Cells
Flanders Institute for Biotechnology, Vrije Universiteit Brussels 
Damya Laoui, Ph.D., is a research scientist in the lab of Jo Van Ginderacter. After her post-doc in the De Palma 
lab at the ISREC Institute in the Ecole Polytechnique de Lausanne, she came back to Brussels where she leads 
her own team focusing on tumor-immunology. She is exploring the role of the immune system in tumor 
progression and is developing new personalized immunotherapies based on dendritic cells. For her work in 
tumor-immunology she received several prizes.

Apply now – simply fill out the form below
We will process your personal data according to our privacy statement.

General Information

Detailed Information

Please give your details for further inquiries.

* Mandatory field

Questions / Comments

Immuno-oncology supported by Miltenyi Biotec

From basic research to innovative therapies

Click here to find our various immuno-oncology activities: Benefit from our experience, meet the experts, or share your research story.
Immuno-oncology

Copyright © 2020 Miltenyi Biotec and/or its affiliates. All rights reserved.

YouTube Facebook Twitter LinkedIn